Nippon India Pharma Fund - Direct Plan - Growth Plan - Regular - Latest NAV [ ₹565.577 ], Returns, Performance, Portfolio & Returns 2025

Nippon India Pharma Fund - Direct Plan - Growth Plan

Very High Risk

Equity

NAV as of Jun 06, 2025

565.58

-0.04%1D Change

Returns since inception

18.35%p.a.

Very High Risk

Equity

NAV as of Jun 06, 2025

565.58

-0.04%1D Change

Returns since inception

18.35%p.a.

Nippon India Pharma Fund - Direct Plan - Growth Plan

Very High Risk|Equity
NAV as of Jun 06, 2025

565.58

-0.04%1D

Returns since inception

18.35%p.a.

Created with Highcharts 9.3.3Jul '22Sep '22Nov '22Jan '23Mar '23May '23Jul '23Sep '23Nov '23Jan '24Mar '24May '24Jul '24Sep '24Nov '24Jan '25Mar '25May '251M3M6M1Y3Y5YMaxFundEquity

Returns calculator

Investment Type

Monthly SIP
One-Time
4000
20
yrs
Total investment₹9.6 Lakhs
Returns89.13 Lakhs
Final Value98.73 Lakhs
Absolute Return928.48%

Fund overview

  • RatingNo Rating
  • Expense ratio0.89%
  • Exit Load1% within 31 days
  • AUM (Fund size)₹8,259.6 Crore
  • Lock-in periodNo Lock-in
  • Age12 yrs since Jan 01, 2013
  • Min. investmentSIP ₹500 & Lump. ₹5000
  • RiskVery High
  • Short-term capital gains (STCG)Returns taxed at 20% if you redeem before 1 year
  • Long-term capital gains (LTCG)After 1 year, pay tax of 12.5% on returns of ₹1.25 lakh+ in a financial year

Fund Distribution

Equity
99.46%
Debt
0%
Others
0.54%
Created with Highcharts 9.3.3
Large Cap
37.81%
Mid Cap
33.5%
Small Cap
28.14%
Top Holdings
Top Sectors
Holding NameAssets (%)
Sun Pharmaceuticals Industries Ltd13.88%
Divi's Laboratories Ltd9.57%
Lupin Ltd6.3%
Cipla Ltd6.01%
Apollo Hospitals Enterprise Ltd5.48%

Peer Comparison

Overview
Returns
Risk Ratios
Fund NameAUM (In Crs.)NAVRisk
ICICI Prudential Pharma H...₹ 5,295 Cr
₹41.81 | 0.22%
Very High
UTI Healthcare Fund-Growt...₹ 1,062 Cr
₹315.02 | 0.00%
Very High
SBI Healthcare Opportunit...₹ 3,671 Cr
₹481.48 | 0.72%
Very High
DSP Healthcare Fund Direc...₹ 1,730 Cr
₹28.35 | 0.57%
Very High

NAV History - NIPPON INDIA PHARMA FUND - Direct Plan - Growth

FUND

NIPPON INDIA PHARMA FUND - Direct Plan - Growth

NAV (Jun 06, 2025)₹565.58
ClassEquity | Sector - Healthcare
Inception DateJan 01, 2013
Fund ManagerSailesh Raj Bhan, Kinjal Desai

FUND

NIPPON INDIA PHARMA FUND - Direct Plan - Growth

Initial Price₹10
Min. Investment AmountSIP ₹500 and Lump. ₹5000
Exit Load1% within 31 days

Returns

1W

1M

3M

6M

1Y

3Y

NIPPON INDIA PHARMA ...0.53%2.37%9.8%-1.38%16.59%25.61%

About Nippon Life India Asset Management Ltd

Nippon India Mutual Fund was launched as a joint venture between Japan's Nippon Life Insurance Company and India's Reliance Capital way back in 1996. Nippon purchased the stake of Reliance in October 2019 and the fund house has been renamed as Nippon India Mutual Fund. It has Nippon Life Insurance Company as the sponsor and Reliance Capital Trustee Co. Ltd. as the trustee. Nippon India Mutual Fund had assets under management of a massive Rs 2,00,030 crore as of September 2020.

Nippon Life India Asset Management Ltd Details

  • No. of schemes273
  • Total AUM₹2,28,586.39 Crore
  • AddressNippon Life India Asset Management Limited, 4th Floor, Tower A, Peninsula Business Park, Mumbai, Maharashtra, 400 013
  • Phone022-6808 7000/18602660111

Frequently Asked Questions

Start your investment
Lumpsum
SIP
Amount
Estimated value after 3 years

(as per historical returns)

2.72 Lakhs ₹
Min investment of ₹500 required